TABLE 3.
Study | Data set | Species and strain | Group size | Tissue | Endpoint | Exposure concentration | Frequency and duration | CI a BMDL (ppm) | CI BMD a (ppm) | Total UF b | PDE (ppt) from CI BMDL | PDE (ppt) from CI BMD |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Manjanatha et al. (2017) | 2 | Mouse, big blue B6C3F1 | 10 | LU | cII | 0, 100, and 200 ppm | 6 hr/day, 5 days/week; 8 weeks | 8.1 | 20 | 3,162 c | 2,547 | 6,409 |
Manjanatha et al. (2017) | 3 | Mouse, big blue B6C3F1 | 10 | LU | cII | 0, 100, 200 ppm | 6 hr/day, 5 days/week; 12 weeks | 25 | 35 | 1,581 d | 15,924 | 22,407 |
Parsons et al. ( 2013 ) | 1 | Mouse—big blue B6C3F1 | 10 | LU | K‐ras | 0, 10, 50, 100, and 200 ppm | 6 hr/day, 5 days/week; 4 weeks | 0.29 | 2.1 | 3,162 c | 92 | 670 |
Parsons et al. ( 2013 ) | 2 | Mouse—big blue B6C3F1 | 10 | LU | K‐ras | 0, 10, 50, 100, and 200 ppm | 6 hr/day, 5 days/week; 4 weeks | 0.19 | 1.2 | 3,162 c | 60 | 375 |
Recio et al. (2004) | 1 | Mouse, B6C3F1 | 6 | BM | lacI | 0, 25, 50, 100, and 200 ppm | 6 hr/days, 5 days/week; 48 weeks | 5.5 | 15 | 316 e | 17,505 | 47,344 |
Recio et al. (2004) | 2 | Mouse, B6C3F1 | 6 | TE | lacI | 0, 25, 50, 100, and 200 ppm | 6 hr/day, 5 days/week; 48 weeks | 0.09 | 0.45 | 316 e | 285 | 1,434 |
van Sittert et al. (2000) | 1 | Rat—Lewis | 6–8 | SL | Hprt | 0, 50, 100, and 200 ppm | 6 hr/day, 5 days/week; 4 weeks | 9 | 20 | 3,162 c | 2,790 | 6,212 |
Walker et al. (1997) | 1 | Mouse, B6C3F1 | 7–9 | SL | Hprt | 0, 50, 100, and 200 ppm | 6 hr/day, 5 days/week; 4 weeks | 4 | 6.4 | 3,162 c | 1,203 | 2,013 |
Note: Inhalation studies that reported variability of the data (SD or SEM) were used for PDE consideration are bolded. For reference (italicized), the PDE for inhalation studies that did not report variability were derived by dividing the BMDL by 5 (see the text).
Abbreviations: BM, bone marrow; CI, continuous inhalation; cII, cII mutation; Hprt, hprt mutation; lacI, lacI mutation; K‐ras, K‐ras mutation; LU, lung cells; SL, splenic lymphocytes; SP, splenocytes; TE, testes.
Modeled BMD and BMDL are adjusted to 24 hr/day and 7 days/week continuous exposure (see the text).
Total UF—total uncertainty factor based on F1 for interspecies toxicokinetic, F2 for inter‐individual variability, F3 for study duration, and F4 for effect severity (see the text).
Total UF based on F1 (TD only) 3.16, F2 10, F3 10, and F4 10.
Total UF based on F1 (TD only) 3.16, F2 10, F3 5, and F4 10.
Total UF based on F1 (TD only) 3.16, F2 10, F3 1, and F4 10.